Effect of Music Therapy on Patients Undergoing Intravitreal Injections
|ClinicalTrials.gov Identifier: NCT00702039|
Recruitment Status : Completed
First Posted : June 19, 2008
Last Update Posted : January 17, 2018
Multiple studies in various specialties, including ophthalmology, are reported in the literature that show that playing music during a procedure (dubbed music therapy) increases patient satisfaction and may reduce patient anxiety and stress levels.
There is no study in the literature that assesses the effects of listening to music in patients undergoing intravitreal injections. This study aims to assess whether listening to music improves patient satisfaction or reduces their anxiety levels in subjects undergoing intravitreal injections.
|Condition or disease||Intervention/treatment|
|Intravitreal Injections Patient Satisfaction Patient Anxiety||Other: No Music Other: Music Therapy|
|Study Type :||Observational|
|Actual Enrollment :||50 participants|
|Official Title:||Effect of Music Therapy on Patients Undergoing Intravitreal Injections|
|Study Start Date :||February 2007|
|Actual Primary Completion Date :||February 2009|
|Actual Study Completion Date :||June 2011|
Those patients receiving intravitreal injections who will be listening to classical music during injection.
Other: Music Therapy
Classical music being played during intravitreal injection.
Those patients receiving intravitreal injections who will not be listening to any music during injection.
Other: No Music
No music will be played in patients in arm 2 of the study.
- This study aims to assess what affects music therapy has on patients receiving intravitreal injections. The subject will take a Satisfaction Survey after the procedure and an Anxiety Survey before and after the injection. [ Time Frame: Before and after the subject's intravitreal injection. ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00702039
|United States, Connecticut|
|Yale Eye Center|
|New Haven, Connecticut, United States, 06510|
|Principal Investigator:||Ron Adelman, MD||Yale University Department of Ophthalmology|